Skip to main content
DAIICHI SANKYO COMPANY, LIMITED logo

DAIICHI SANKYO COMPANY, LIMITED — Investor Relations & Filings

Ticker · 4568 ISIN · JP3475350009 LEI · 353800XGIU2IHQGC9504 T Manufacturing
Open in API
Filings indexed 102 across all filing types
Latest filing 2026-05-18 Remuneration Information
Country JP Japan
Listing T 4568

About DAIICHI SANKYO COMPANY, LIMITED

https://www.daiichisankyo.co.jp/

Daiichi Sankyo is an innovative global healthcare company focused on the research, development, and delivery of pharmaceutical solutions. By leveraging cutting-edge science, technology, and data analytics, the company develops novel medicines and medical treatments to address unmet needs. Its core mission is to contribute to the enrichment of quality of life for patients worldwide. The company maintains a robust R&D pipeline and actively engages in open innovation to advance its therapeutic offerings, with a significant focus on oncology and specialty medicines.

Recent filings

Filing Released Lang Actions
当社取締役等に対する中計業績連動株式報酬等の内容の一部改定に関するお知らせ
Remuneration Information Classification · 89% confidence The document is a Japanese company press release (“お知らせ”) detailing amendments to its mid-term performance-linked stock remuneration plan for directors and executive officers. It provides in-depth information on a compensation scheme for senior management and is to be proposed at the upcoming shareholder meeting. This clearly falls under “Remuneration Information” (DEF 14A), which covers reports detailing executive and director compensation plans. It is not an annual/quarterly report, earnings release, or other category, but specifically outlines changes to executive remuneration structures.
2026-05-18 Japanese
（訂正）「2025年度 決算補足資料」の一部訂正について
Report Publication Announcement Classification · 75% confidence The document is a brief correction notice (“訂正”) to the already‐published FY2025 earnings supplementary materials, providing a link to the updated PDF and showing only the corrected table. It does not contain a full earnings release or annual report but simply announces the publication of a corrected report. Under the “menu vs. meal” rule, this type of short notice with a link to the updated document is classified as a Report Publication Announcement (RPA).
2026-05-13 Japanese
2025年度決算および第6期（2026-2030年度）中期経営計画　説明会
Investor Presentation Classification · 95% confidence The document is a detailed slide deck titled “2025年度決算 および 第6期（2026-2030年度）中期経営計画 説明会” by Daiichi-Sankyo dated May 11, 2026. It contains consolidated financial results for the full 2025 fiscal year, forward-looking performance forecasts for 2026, business and R&D updates, mid-term strategic planning, and charts/graphs. It is clearly an investor relations presentation (決算説明会資料) rather than a formal annual report (10-K), interim report, press release, or regulatory notice. Therefore, it should be classified as an Investor Presentation (IP).
2026-05-11 Japanese
決算補足資料（2025年度決算）
Financial Supplement Data Classification · 85% confidence The document is titled “決算補足資料” (earnings supplemental materials) for fiscal year 2025 and contains detailed financial tables—income statements, balance sheets, cash flows, segment/product sales breakdowns, forecasts, and adjustment schedules. It is clearly an earnings appendix containing granular financial data (not just a high‐level summary), but it is not the full audited Annual Report (10-K) nor a statutory interim report (IR) nor merely an announcement (RPA). It serves the same purpose as “financial supplement” data accompanying earnings releases. Therefore, it best matches the “Financial Supplement Data” category (XLSX).
2026-05-11 Japanese
2026年3月期 決算短信〔IFRS〕（連結）
Earnings Release Classification · 92% confidence The document is a Japanese “kessan tanshin” (決算短信) – a detailed earnings release for the fiscal year ending March 2026 under IFRS, containing full results, forecasts, segment breakdowns, and actual financial data. It is not an audited Annual Report (10-K) nor purely a notice of report publication (RPA/RNS), but the initial, substantive financial results announcement. Therefore it maps to the “Earnings Release” category. FY 2026
2026-05-11 Japanese
自己株式の消却に関するお知らせ
Share Issue/Capital Change Classification · 85% confidence The document is an official notice from Daiichi Sankyo concerning the cancellation of treasury shares (自己株式の消却). It describes a board resolution under the Companies Act, the number of shares to be canceled, and the cancellation date. This is a corporate action affecting capital structure (capital change) rather than an actual financial report or dividend notice. It falls under the category for share issue/capital change.
2026-05-11 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.